Lipella Pharmaceuticals Common Stock Volume Indicators On Balance Volume

LIPO Stock   2.80  0.16  5.41%   
Lipella Pharmaceuticals volume indicators tool provides the execution environment for running the On Balance Volume indicator and other technical functions against Lipella Pharmaceuticals. Lipella Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the On Balance Volume indicator function is designed to identify and follow existing trends. Lipella Pharmaceuticals volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The On Balance Volume indicator was developed by Joe Granville to show time series momentum that relates Lipella Pharmaceuticals volume to price change. It can show when Lipella Pharmaceuticals is accumulated or sold by a large number of investors.

Lipella Pharmaceuticals Technical Analysis Modules

Most technical analysis of Lipella Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lipella from various momentum indicators to cycle indicators. When you analyze Lipella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lipella Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lipella Pharmaceuticals Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lipella Pharmaceuticals Common based on widely used predictive technical indicators. In general, we focus on analyzing Lipella Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lipella Pharmaceuticals's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Lipella Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Lipella Pharmaceuticals, we also check how macroeconomic factors affect Lipella Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2023 2024 (projected)
Current Ratio5.318.99.34
Net Debt To EBITDA1.810.690.65
Hype
Prediction
LowEstimatedHigh
0.142.8010.72
Details
Intrinsic
Valuation
LowRealHigh
0.132.5210.44
Details
Naive
Forecast
LowNextHigh
0.063.0710.99
Details
1 Analysts
Consensus
LowTargetHigh
1.822.002.22
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Banking Idea
Banking
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Social Domain Idea
Social Domain
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Business Services Idea
Business Services
Invested over 100 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
When determining whether Lipella Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipella Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipella Pharmaceuticals Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipella Pharmaceuticals Common Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.88)
Revenue Per Share
0.592
Quarterly Revenue Growth
0.279
Return On Assets
(0.94)
Return On Equity
(1.72)
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.